We have not looked at that using our own data. Patients who relapse should be encouraged to try again. Your program stresses an individualized approach to treating nicotine dependence. I like to use an analogy to the care of the patient with diabetes. No one would ever recommend that all diabetics be treated with the same dose of insulin.
Every smoker is an individual.
Based on the amounts that they smoke along with a clinical assessment of depression and stress, we try to come up with an individualized treatment program. I noticed that in a recent article you recommend giving higher doses of nicotine replacement than are recommended in the product literature. That may be because the amount of nicotine they get with currently recommended doses is sufficient to treat their symptoms. Patients who have higher initial cotinine levels need a higher dose of replacement therapy to achieve similar outcomes. Rather than look at a single glucose level, physicians look at the glycosylated hemoglobin level because it gives a picture of glucose control over time.